Advertisement

Topics

Novo Nordisk, Inc. Company Profile

12:47 EST 20th February 2017 | BioPortfolio

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.


News Articles [773 Associated News Articles listed on BioPortfolio]

Novo Nordisk - Team Novo Nordisk ist in Neuseeland im Rennen!

Lieber Leser, die Sponsoraktivitäten von Novo Nordisk konzentrieren sich auf Sensibilisierungs- und Gesundheitsförderungsmaßnahmen, so wie es bei dem Team Novo Nordisk um die Vorbeugung von Diabete...

Novo Nordisk: Korrektur abgeschlossen

Lieber Leser, im Laufe der letzten 7 Tage gab es diverse Studien-Updates von Analysten für Novo Nordisk. Aus gutem Grund: Anfang August senkte Novo Nordisk seine Prognose für das Geschäftsjahr 2016...

Novo Nordisk Falls Sharply After Slashing Growth Forecast

WASHINGTON (dpa-AFX) - Novo Nordisk (NVO) has moved sharply lower during trading on Friday, with the Danish pharmaceutical company slumping by 14.5 percent. With the drop, shares of Novo Nordisk h...

Novo Nordisk irritiert bzw. Tesla und Uber (Top Media Extended)

Novo Nordisk irritiert >> Bildauswahl durch die BSNgine, zum Originalzusammenhang » (Peer Group Watch Runplugged Running... » TTM Technologies, Inc. und Unimicron... Bittere Pille für Novo Nordisk ...

Novo Nordisk: Jetzt heißt es aufpassen

Die Novo Nordisk Aktie steigt zum Start in die neue Woche um über 1%. Dennoch könnte der Kampf um die 30-Euro-Marke in dieser Woche spannend werden und Anleger von Novo Nordisk müssen weiter stark...

#jobs #lifescience The Novo Nordisk Foundation: Novo Nordisk Foundation Young Investigator Awards

// TBD: The Novo Nordisk Foundation: YOUNG INVESTIGATOR AWARDS. International Call for Applications within the areas of biomedicine & biotechnology. Grants up to 20 million Danish kroner Denmark ...

Novo Nordisk A/S: Novo Nordisk files for regulatory approval of once-weekly semaglutide in the US and EU for the treatment of type 2 diabetes

Bagsværd, Denmark, 5 December 2016 - Novo Nordisk today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) and a Marketing Authorisation Applicat...

Sanofi files lawsuit against Novo Nordisk over 'false allegations'

Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the claim on the pretext that Novo Nordisk claimed that Sanofi’s insulin drugs would b...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Physicians Total Care, Inc.]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

R HUMAN Novolin R Regular, Human Insulin Injection (recombinant DNA origin) USP 100 units/mL

PubMed Articles [293 Associated PubMed Articles listed on BioPortfolio]

Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.

Recent research has uncovered an important role for de novo variation in neurodevelopmental disorders. Using aggregated data from 9,246 families with autism spectrum disorder, intellectual disability,...

Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.

Therapy-related acute myeloid leukemia (T-AML) is associated with poor prognosis after conventional therapy. Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as a treatment f...

Replication Errors Made During Oogenesis Lead to Detectable De Novo mtDNA Mutations in Zebrafish Oocytes with a Low mtDNA Copy Number.

Of all pathogenic mitochondrial DNA (mtDNA) mutations in humans, ~25% is de novo, although the occurrence in oocytes has never been directly assessed. We used next generation sequencing to detect poin...

Open-pNovo: De Novo Peptide Sequencing with Thousands of Protein Modifications.

De novo peptide sequencing has improved remarkably but sequencing full-length peptides with unexpected modifications is still a challenging problem. Here we present an open de novo sequencing tool Ope...

Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction.

Computational de novo molecular design and macromolecular target prediction have become routine in applied cheminformatics. In this study, we have generated populations of drug template-derived design...

Clinical Trials [296 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemi...

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

This is a Randomized, Parallel-Group, Placebo- Controlled, Multicenter Study to Evaluate the Therapeutic Equivalence and Safety of Estradiol Vaginal Tablets 10 mcg and Vagifem® (Estradiol...

Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

The aim of this study is to test the safety and efficacy of a new algorithm for intensive s.c. insulin injection in medical emergency patients with hyperglycaemia (plasma glucose concentra...

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and Nov...

Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

This trial is conducted in Europe. The aim of this clinical trial is to compare the metabolism of a blood-clotting drug (recombinant Factor XIII) produced by two different manufacturers (N...

Companies [50 Associated Companies listed on BioPortfolio]

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area ...

Novo Nordisk Inc.

More Information about "Novo Nordisk, Inc." on BioPortfolio

We have published hundreds of Novo Nordisk, Inc. news stories on BioPortfolio along with dozens of Novo Nordisk, Inc. Clinical Trials and PubMed Articles about Novo Nordisk, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novo Nordisk, Inc. Companies in our database. You can also find out about relevant Novo Nordisk, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record